LOC105370913: A Potential Drug Target or Biomarker (G105370913)
LOC105370913: A Potential Drug Target or Biomarker
LOC105370913 (LOC105370913 variant X2) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the superfamily of proteins known as the Leucine-rich repeat (LRR) proteins , which are characterized by the presence of a unique repeat sequence in the protein sequence.
LOC105370913 variant X2 is of particular interest as a potential drug target or biomarker due to its unique structure and expression pattern. The LRR proteins have been shown to play important roles in various cellular processes, including cell signaling, DNA replication, and stress response. Additionally , LRR proteins have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The LOC105370913 protein is a 21-kDa protein that is expressed in the brain, heart, kidneys, and liver. It is characterized by a unique N-terminal region that consists of a singleton cluster of the LRR protein. The LRR region is responsible for the protein's unique structure and stability, as well as its expression pattern in various tissues.
The LOC105370913 variant X2 protein has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response. For example, studies have shown that the LOC105370913 protein is involved in the regulation of cell adhesion, a process that is important for the development and maintenance of tissues and organs. Additionally, the protein has been shown to play a role in DNA replication, which is critical for the maintenance of genetic information in cells.
LOC105370913 variant X2 has also been shown to be involved in stress response, a process that is important for the survival of cells in response to various environmental conditions. Studies have shown that the protein is involved in the regulation of cellular stress responses, including the stress -induced increase in the expression of genes involved in stress response.
The LOC105370913 protein is also of interest as a potential biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that the LOC105370913 protein is involved in the regulation of cellular processes that are associated with the development and progression of cancer. Additionally, the protein has been shown to play a role in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
In conclusion, LOC105370913 (LOC105370913 variant X2) is a unique and highly expressed protein that is characterized by a unique N-terminal region that consists of a singleton cluster of the LRR protein. The LOC105370913 protein has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response. Additionally, the protein has been shown to play a role in the regulation of cellular stress responses and has been implicated in the development and progression of cancer, as well as neurodegenerative diseases. Therefore , LOC105370913 variant X2 is of particular interest as a potential drug target or biomarker.
Protein Name: Uncharacterized LOC105370913
The "LOC105370913 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370913 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483 | LOC105371487 | LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046
